True Wealth Design’s Pliant Therapeutics PLRX Stock Holding History

True Wealth Design’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19	Closed	-$23	–	2842
2025 Q2	$23	Buy	+19	New	+$27	﹤0.01%	2500

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

True Wealth Design's PLRX Position: Q3 2025 in Review

True Wealth Design sold out of Pliant Therapeutics (PLRX) in Q3 2025, closing a stake of 19 shares — an estimated $23 sold.

True Wealth Design first reported a position in PLRX in Q2 2025 and held it in 1 quarter. The position peaked at $23 in Q2 2025. 99 funds tracked by Wall St. Rank hold PLRX as of Q3 2025.

True Wealth Design reported no remaining Pliant Therapeutics position as of Q3 2025 after selling out during the quarter.
True Wealth Design sold 19 Pliant Therapeutics shares in Q3 2025, an estimated $23.
True Wealth Design first reported a position in Pliant Therapeutics in Q2 2025 and held it in 1 quarter.
True Wealth Design's Pliant Therapeutics position peaked at $23 in Q2 2025.
99 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.